US Stock MarketDetailed Quotes

Bristol-Myers Squibb (BMY)

Watchlist

58.710
-0.310-0.53%

Close Apr 24 16:00 ET

58.700
-0.010-0.02%

Pre 07:09 ET

119.87BMarket Cap16.97P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bristol-Myers Squibb (BMY) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Total revenue

-0.22%48.2B

1.30%12.5B

2.77%12.22B

0.56%12.27B

-5.60%11.2B

7.32%48.3B

7.54%12.34B

8.44%11.89B

8.69%12.2B

4.66%11.87B

Operating revenue

-0.11%47.2B

2.44%12.23B

3.34%11.98B

-0.11%12.03B

-6.15%10.97B

6.47%47.26B

5.48%11.94B

7.47%11.59B

8.52%12.04B

4.48%11.69B

Cost of revenue

-0.23%13.94B

-14.86%4.1B

16.17%3.44B

3.21%3.37B

3.44%3.03B

30.63%13.97B

75.30%4.81B

18.00%2.96B

13.60%3.27B

14.26%2.93B

Gross profit

-0.21%34.26B

11.63%8.41B

-1.66%8.79B

-0.41%8.9B

-8.56%8.17B

0.06%34.33B

-13.77%7.53B

5.61%8.94B

6.99%8.93B

1.85%8.93B

Operating expense

-27.81%20.54B

-20.33%5.59B

-23.88%5.15B

-29.27%5.12B

-37.04%4.67B

8.91%28.45B

2.80%7.02B

4.03%6.76B

12.31%7.24B

17.04%7.42B

Selling and administrative expenses

-13.63%7.27B

2.11%2.18B

-9.78%1.79B

-11.15%1.71B

-33.08%1.58B

8.26%8.41B

3.04%2.14B

-1.00%1.98B

-0.31%1.93B

34.34%2.37B

-Selling and marketing expense

----

-33.08%1.58B

----

-1.00%1.98B

----

34.34%2.37B

Research and development costs

-10.83%9.95B

-18.96%2.59B

6.49%2.53B

-11.00%2.58B

-16.25%2.26B

20.00%11.16B

28.77%3.19B

5.89%2.37B

28.39%2.9B

16.11%2.7B

Depreciation amortization depletion

-62.61%3.32B

-51.21%826M

-65.46%831M

-65.65%830M

-64.79%830M

-1.93%8.87B

-25.68%1.69B

6.65%2.41B

7.04%2.42B

4.48%2.36B

-Depreciation and amortization

-62.61%3.32B

-51.21%826M

-65.46%831M

-65.65%830M

-64.79%830M

-1.93%8.87B

-25.68%1.69B

6.65%2.41B

7.04%2.42B

4.48%2.36B

Operating profit

133.12%13.72B

451.57%2.81B

67.54%3.64B

123.18%3.77B

130.98%3.5B

-28.16%5.89B

-73.20%510M

10.87%2.17B

-11.05%1.69B

-37.75%1.51B

Net non-operating interest income expense

2.88%-1.89B

12.90%-432M

4.95%-480M

6.91%-485M

-16.24%-494M

-66.98%-1.95B

-56.96%-496M

-80.36%-505M

-84.75%-521M

-47.57%-425M

Non-operating interest expense

-2.88%1.89B

-12.90%432M

-4.95%480M

-6.91%485M

16.24%494M

66.98%1.95B

56.96%496M

80.36%505M

84.75%521M

47.57%425M

Other net income (expense)

79.67%-2.5B

-664.60%-909M

-588.89%-44M

-1,407.76%-1.52B

99.74%-33M

-973.07%-12.32B

85.06%161M

-98.03%9M

-51.67%116M

-2,113.58%-12.61B

Gain on sale of security

3.24%510M

80.22%-18M

231.13%351M

-39.69%117M

-78.95%60M

70.93%494M

-145.96%-91M

-0.93%106M

424.32%194M

637.74%285M

Special income (charges)

63.78%-5.23B

-1,011.89%-1.59B

-99.34%-909M

-292.35%-2.1B

95.33%-621M

-1,141.48%-14.43B

79.92%-143M

-87.65%-456M

-65.94%-536M

-11,557.76%-13.29B

-Less：Restructuring and merger&acquisition

-66.59%4.79B

792.66%1.58B

81.91%744M

350.11%2.1B

-97.26%364M

824.10%14.34B

-76.02%177M

48.73%409M

41.52%467M

6,258.37%13.29B

-Less:Impairment of capital assets

----

--0

----

62.07%47M

--0

62.07%47M

----

-Less:Other special charges

416.67%434M

-23.08%10M

--165M

-98.55%1M

12,750.00%257M

121.54%84M

333.33%13M

----

1,085.71%69M

100.62%2M

-Gain on sale of business

----

---15M

----

Other non- operating income (expenses)

37.07%2.21B

76.96%699M

43.18%514M

2.40%469M

31.67%528M

-29.38%1.61B

-34.28%395M

-39.56%359M

-12.93%458M

-28.77%401M

Income before tax

211.33%9.33B

740.00%1.47B

85.80%3.11B

37.87%1.77B

125.80%2.97B

-199.28%-8.38B

-89.55%175M

-21.57%1.68B

-30.82%1.29B

-515.74%-11.52B

Income tax

310.11%2.27B

287.88%384M

99.35%919M

215.58%460M

29.85%509M

38.50%554M

212.50%99M

127.09%461M

-82.57%-398M

-22.07%392M

Net income

178.98%7.06B

1,327.63%1.09B

80.66%2.2B

-22.03%1.31B

120.68%2.46B

-211.11%-8.93B

-95.69%76M

-37.18%1.22B

-18.92%1.68B

-625.28%-11.91B

Net income continuous Operations

178.98%7.06B

1,327.63%1.09B

80.66%2.2B

-22.03%1.31B

120.68%2.46B

-211.11%-8.93B

-95.69%76M

-37.18%1.22B

-18.92%1.68B

-625.28%-11.91B

Minority interest income

-86.67%2M

-125.00%-1M

-250.00%-6M

-50.00%2M

100.00%6M

0.00%15M

-33.33%4M

0.00%4M

-40.00%3M

Net income attributable to the parent company

178.83%7.05B

1,409.72%1.09B

81.75%2.2B

-22.02%1.31B

120.62%2.46B

-211.50%-8.95B

-95.91%72M

-37.19%1.21B

-18.96%1.68B

-626.57%-11.91B

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

178.83%7.05B

1,409.72%1.09B

81.75%2.2B

-22.02%1.31B

120.62%2.46B

-211.50%-8.95B

-95.91%72M

-37.19%1.21B

-18.96%1.68B

-626.57%-11.91B

Basic earnings per share

178.68%3.47

1,225.00%0.53

80.00%1.08

-22.89%0.64

120.54%1.21

-213.66%-4.41

-95.40%0.04

-36.17%0.6

-16.16%0.83

-645.37%-5.89

Diluted earnings per share

178.46%3.46

1,225.00%0.53

80.00%1.08

-22.89%0.64

120.37%1.2

-214.25%-4.41

-95.40%0.04

-35.48%0.6

-16.16%0.83

-650.47%-5.89

Dividend per share

2.89%2.49

1.61%0.63

3.33%0.62

4.76%2.42

3.33%0.62

5.26%0.6

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Total revenue	-0.22%48.2B	1.30%12.5B	2.77%12.22B	0.56%12.27B	-5.60%11.2B	7.32%48.3B	7.54%12.34B	8.44%11.89B	8.69%12.2B	4.66%11.87B
Operating revenue	-0.11%47.2B	2.44%12.23B	3.34%11.98B	-0.11%12.03B	-6.15%10.97B	6.47%47.26B	5.48%11.94B	7.47%11.59B	8.52%12.04B	4.48%11.69B
Cost of revenue	-0.23%13.94B	-14.86%4.1B	16.17%3.44B	3.21%3.37B	3.44%3.03B	30.63%13.97B	75.30%4.81B	18.00%2.96B	13.60%3.27B	14.26%2.93B
Gross profit	-0.21%34.26B	11.63%8.41B	-1.66%8.79B	-0.41%8.9B	-8.56%8.17B	0.06%34.33B	-13.77%7.53B	5.61%8.94B	6.99%8.93B	1.85%8.93B
Operating expense	-27.81%20.54B	-20.33%5.59B	-23.88%5.15B	-29.27%5.12B	-37.04%4.67B	8.91%28.45B	2.80%7.02B	4.03%6.76B	12.31%7.24B	17.04%7.42B
Selling and administrative expenses	-13.63%7.27B	2.11%2.18B	-9.78%1.79B	-11.15%1.71B	-33.08%1.58B	8.26%8.41B	3.04%2.14B	-1.00%1.98B	-0.31%1.93B	34.34%2.37B
-Selling and marketing expense	----	----	----	----	-33.08%1.58B	----	----	-1.00%1.98B	----	34.34%2.37B
Research and development costs	-10.83%9.95B	-18.96%2.59B	6.49%2.53B	-11.00%2.58B	-16.25%2.26B	20.00%11.16B	28.77%3.19B	5.89%2.37B	28.39%2.9B	16.11%2.7B
Depreciation amortization depletion	-62.61%3.32B	-51.21%826M	-65.46%831M	-65.65%830M	-64.79%830M	-1.93%8.87B	-25.68%1.69B	6.65%2.41B	7.04%2.42B	4.48%2.36B
-Depreciation and amortization	-62.61%3.32B	-51.21%826M	-65.46%831M	-65.65%830M	-64.79%830M	-1.93%8.87B	-25.68%1.69B	6.65%2.41B	7.04%2.42B	4.48%2.36B
Operating profit	133.12%13.72B	451.57%2.81B	67.54%3.64B	123.18%3.77B	130.98%3.5B	-28.16%5.89B	-73.20%510M	10.87%2.17B	-11.05%1.69B	-37.75%1.51B
Net non-operating interest income expense	2.88%-1.89B	12.90%-432M	4.95%-480M	6.91%-485M	-16.24%-494M	-66.98%-1.95B	-56.96%-496M	-80.36%-505M	-84.75%-521M	-47.57%-425M
Non-operating interest expense	-2.88%1.89B	-12.90%432M	-4.95%480M	-6.91%485M	16.24%494M	66.98%1.95B	56.96%496M	80.36%505M	84.75%521M	47.57%425M
Other net income (expense)	79.67%-2.5B	-664.60%-909M	-588.89%-44M	-1,407.76%-1.52B	99.74%-33M	-973.07%-12.32B	85.06%161M	-98.03%9M	-51.67%116M	-2,113.58%-12.61B
Gain on sale of security	3.24%510M	80.22%-18M	231.13%351M	-39.69%117M	-78.95%60M	70.93%494M	-145.96%-91M	-0.93%106M	424.32%194M	637.74%285M
Special income (charges)	63.78%-5.23B	-1,011.89%-1.59B	-99.34%-909M	-292.35%-2.1B	95.33%-621M	-1,141.48%-14.43B	79.92%-143M	-87.65%-456M	-65.94%-536M	-11,557.76%-13.29B
-Less：Restructuring and merger&acquisition	-66.59%4.79B	792.66%1.58B	81.91%744M	350.11%2.1B	-97.26%364M	824.10%14.34B	-76.02%177M	48.73%409M	41.52%467M	6,258.37%13.29B
-Less:Impairment of capital assets	----	----	--0	----	----	62.07%47M	--0	62.07%47M	----	----
-Less:Other special charges	416.67%434M	-23.08%10M	--165M	-98.55%1M	12,750.00%257M	121.54%84M	333.33%13M	----	1,085.71%69M	100.62%2M
-Gain on sale of business	----	----	----	----	----	---15M	----	----	----	----
Other non- operating income (expenses)	37.07%2.21B	76.96%699M	43.18%514M	2.40%469M	31.67%528M	-29.38%1.61B	-34.28%395M	-39.56%359M	-12.93%458M	-28.77%401M
Income before tax	211.33%9.33B	740.00%1.47B	85.80%3.11B	37.87%1.77B	125.80%2.97B	-199.28%-8.38B	-89.55%175M	-21.57%1.68B	-30.82%1.29B	-515.74%-11.52B
Income tax	310.11%2.27B	287.88%384M	99.35%919M	215.58%460M	29.85%509M	38.50%554M	212.50%99M	127.09%461M	-82.57%-398M	-22.07%392M
Net income	178.98%7.06B	1,327.63%1.09B	80.66%2.2B	-22.03%1.31B	120.68%2.46B	-211.11%-8.93B	-95.69%76M	-37.18%1.22B	-18.92%1.68B	-625.28%-11.91B
Net income continuous Operations	178.98%7.06B	1,327.63%1.09B	80.66%2.2B	-22.03%1.31B	120.68%2.46B	-211.11%-8.93B	-95.69%76M	-37.18%1.22B	-18.92%1.68B	-625.28%-11.91B
Minority interest income	-86.67%2M	-125.00%-1M	-250.00%-6M	-50.00%2M	100.00%6M	0.00%15M	4M	-33.33%4M	0.00%4M	-40.00%3M
Net income attributable to the parent company	178.83%7.05B	1,409.72%1.09B	81.75%2.2B	-22.02%1.31B	120.62%2.46B	-211.50%-8.95B	-95.91%72M	-37.19%1.21B	-18.96%1.68B	-626.57%-11.91B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	178.83%7.05B	1,409.72%1.09B	81.75%2.2B	-22.02%1.31B	120.62%2.46B	-211.50%-8.95B	-95.91%72M	-37.19%1.21B	-18.96%1.68B	-626.57%-11.91B
Basic earnings per share	178.68%3.47	1,225.00%0.53	80.00%1.08	-22.89%0.64	120.54%1.21	-213.66%-4.41	-95.40%0.04	-36.17%0.6	-16.16%0.83	-645.37%-5.89
Diluted earnings per share	178.46%3.46	1,225.00%0.53	80.00%1.08	-22.89%0.64	120.37%1.2	-214.25%-4.41	-95.40%0.04	-35.48%0.6	-16.16%0.83	-650.47%-5.89
Dividend per share	2.89%2.49	1.61%0.63	3.33%0.62	3.33%0.62	3.33%0.62	4.76%2.42	3.33%0.62	5.26%0.6	5.26%0.6	5.26%0.6
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

United Microelectronics

Middle East conflict spreads to the stock market! How should investors respond?

According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm